ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.49
-0.43%
US Tech 100
19,533.20
0.64%
S&P 500
5,487.03
0.25%
US Dollar vs CAD
1.37187
0.09%
Bitcoin
65,619.65
1.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MaxCyte Inc (MXCT)

  7. MaxCyte Inc (MXCT) News

MXCT MaxCyte Inc

4.41
0.00 (0.00%)
Pre Market
Last Updated: 03:09:35
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
MaxCyte Inc MXCT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 4.41 03:09:35
Open Price Low Price High Price Close Price Previous Close
4.41
more quote information »

Recent News

Date Time Source Heading
6/13/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/12/202415:45EDGAR2Form 8-K - Current report
6/10/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202407:05GLOBEMaxCyte to Participate in William Blair 44th Annual Growth..
5/22/202407:05GLOBEMaxCyte Signs Strategic Platform License Agreement with..
5/07/202416:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202415:14EDGAR2Form 8-K - Current report
5/07/202415:05GLOBEMaxCyte Reports First Quarter 2024 Financial Results and..
4/10/202407:05GLOBEMaxCyte to Report First Quarter 2024 Financial Results on..
4/02/202407:05GLOBEMaxCyte Signs Strategic Platform License with Be Biopharma..
3/12/202415:05GLOBEMaxCyte Reports Fourth Quarter and Full Year 2023 Financial..
3/05/202415:15EDGAR2Form 8-K - Current report
3/04/202416:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/04/202415:05GLOBEMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023..
2/26/202415:22EDGAR2Form 144 - Report of proposed sale of securities
2/14/202415:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202411:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/09/202407:05GLOBEMaxCyte to Report Fourth Quarter and Full Year 2023..
2/01/202415:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/30/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202407:05GLOBEMaxCyte and Wugen Sign Strategic Platform License to..
1/26/202415:45EDGAR2Form 8-K - Current report
1/26/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/23/202407:05GLOBEMaxCyte Signs Strategic Platform License with Imugene to..
1/08/202415:15EDGAR2Form 8-K - Current report
1/08/202415:05GLOBEMaxCyte Announces Preliminary Unaudited Fourth Quarter and..
1/04/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202407:05GLOBEMaxCyte and Lion TCR form Partnership to Support Global..
1/02/202401:00GLOBEMaxCyte Confirms Appointment of Maher Masoud as President,..
12/28/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:30EDGAR2Form 8-K - Current report
12/11/202315:05GLOBEMaxCyte Announces CEO Transition and Updates Revenue..
12/06/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202315:32EDGAR2Form 144 - Report of proposed sale of securities
11/17/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/16/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202307:05GLOBEMaxCyte Joins the Alliance for mRNA Medicines (AMM) as a..
11/08/202316:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:12EDGAR2Form 8-K - Current report
11/08/202315:05GLOBEMaxCyte Reports Third Quarter 2023 Financial Results and..
11/06/202315:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
10/04/202315:14EDGAR2Form 8-K - Current report
10/04/202315:05GLOBEMaxCyte Announces Preliminary Third Quarter 2023 Revenue and..

Your Recent History

NASDAQ
MXCT
MaxCyte
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved